An initial analysis of pooled CRC specimens suggested opposing effects of non-synonymous PTEN mutations and PTEN deletions, with PTEN deletions associated with shorter survival (median overall survival (OS) 31.3 versus 63.2 months), but PTEN mutations with better survival (median OS not reached but >150 months). This evidence concerns the gene PTEN and colorectal carcinoma.